We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Avista
AVA
$3.24B
| $231K | 0.02% |
5,689
-17,796
| -76% | -$731K |
|
1152
LXP Industrial Trust
LXP
$3.57B
| $231K | 0.02% |
5,099
-4,216
| -45% | -$192K |
|
1153
Peoples Bancorp
PEBO
$1.47B
| $231K | 0.02% |
+7,462
| New | +$239K |
|
1154
National Health Investors
NHI
$3.65B
| $230K | 0.02% |
+2,924
| New | +$232K |
|
|
CLCT
1155
DELISTED
Collectors Universe
CLCT
| $230K | 0.02% |
13,100
+1,000
| +8% | +$15.2K |
|
1156
Addus HomeCare
ADUS
$2.23B
| $229K | 0.02% |
3,600
| – | – |
|
1157
AMC Global Media
AMCX
$489M
| $229K | 0.02% |
4,041
-969
| -19% | -$59.5K |
|
1158
Peapack-Gladstone Financial
PGC
$812M
| $228K | 0.02% |
+8,702
| New | +$239K |
|
|
CY
1159
DELISTED
Cypress Semiconductor
CY
| $228K | 0.02% |
15,302
+1,489
| +11% | +$21.6K |
|
1160
Abbott
ABT
$187B
| $227K | 0.02% |
2,844
-12,056
| -81% | -$897K |
|
1161
Agilysys
AGYS
$3.06B
| $227K | 0.02% |
+10,721
| New | +$198K |
|
1162
Energizer
ENR
$1.55B
| $227K | 0.02% |
+5,058
| New | +$233K |
|
1163
United Parks & Resorts
PRKS
$2.12B
| $227K | 0.02% |
8,804
-4,946
| -36% | -$126K |
|
|
GBT
1164
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $227K | 0.02% |
+4,298
| New | +$211K |
|
|
CHK
1165
DELISTED
Chesapeake Energy Corporation
CHK
| $227K | 0.02% |
+366
| New | +$205K |
|
1166
Asbury Automotive
ABG
$3.85B
| $226K | 0.02% |
+3,252
| New | +$226K |
|
|
SBR
1167
Sabine Royalty Trust
SBR
$1.05B
| $226K | 0.02% |
+4,864
| New | +$211K |
|
|
SNCR
1168
DELISTED
Synchronoss Technologies
SNCR
| $226K | 0.02% |
4,133
-6,078
| -60% | -$395K |
|
1169
Brighthouse Financial
BHF
$3.5B
| $225K | 0.02% |
6,198
-1,288
| -17% | -$48.2K |
|
1170
Darden Restaurants
DRI
$24.4B
| $225K | 0.02% |
1,850
-1,921
| -51% | -$211K |
|
|
EEX
1171
DELISTED
Emerald Holding
EEX
| $225K | 0.02% |
17,700
-405
| -2% | -$5.29K |
|
|
DCP
1172
DELISTED
DCP Midstream, LP
DCP
| $225K | 0.02% |
+6,816
| New | +$218K |
|
|
PMT
1173
PennyMac Mortgage Investment
PMT
$842M
| $224K | 0.02% |
+10,806
| New | +$218K |
|
1174
ITT
ITT
$19.1B
| $223K | 0.02% |
+3,838
| New | +$209K |
|
|
CAMP
1175
DELISTED
CalAmp Corp.
CAMP
| $223K | 0.02% |
770
-334
| -30% | -$106K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.